Repligen (RGEN) Tops Q2 EPS by 27c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $165.66 --0%
Revenue Growth %: -17.9%
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
WF, CWBC, GLTO, More
Revenue Growth %: -17.9%
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.79, $0.27 better than the analyst estimate of $0.52. Revenue for the quarter came in at $163 million versus the consensus estimate of $144.1 million.
GUIDANCE:
Repligen sees FY2021 revenue of $625-645 million, versus the consensus of $585.9 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Chevron (CVX) earnings fall short while revenue tops estimates in Q1
- Portland General Electric (POR) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
